Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Price-Control Reg Raises Concerns Among Manufacturers

This article was originally published in The Gray Sheet

Executive Summary

The Chinese government is floating a revised rule among U.S. and European device industry reps that would place strict price limits on medical devices imported into the country

You may also be interested in...



Nearly 10,000 New Facilities To Be Built In China Under Final Health Plan

Under a health care reform plan finalized April 6, the Chinese government will spend $123 billion by 2011 to expand medical services to the entire nation

Nearly 10,000 New Facilities To Be Built In China Under Final Health Plan

Under a health care reform plan finalized April 6, the Chinese government will spend $123 billion by 2011 to expand medical services to the entire nation

Nearly 10,000 New Facilities To Be Built In China Under Final Health Plan

Device pricing may come under increased pressure with increase in health care access.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel